The influence of phenobarbital on the half-life of diphenylhydantoin in man.

Suppr

超能文献

作者信息

Kristensen M, Hansen J M, Skovsted L

出版信息

Acta Med Scand. 1969 Apr;185(4):347-50. doi: 10.1111/j.0954-6820.1969.tb07346.x.

DOI:10.1111/j.0954-6820.1969.tb07346.x

PMID:5806342

Abstract

摘要

相似文献

The influence of phenobarbital on the half-life of diphenylhydantoin in man.

Acta Med Scand. 1969 Apr;185(4):347-50. doi: 10.1111/j.0954-6820.1969.tb07346.x.

Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.

Ann N Y Acad Sci. 1971 Jul 6;179:88-107. doi: 10.1111/j.1749-6632.1971.tb46892.x.

The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes.

Neurology. 1969 Jun;19(6):611-6. doi: 10.1212/wnl.19.6.611.

Plasma albumin concentration and diphenylhydantoin binding in man.

Arch Neurol. 1975 May;32(5):298-303. doi: 10.1001/archneur.1975.00490470042005.

Phenobarbital does not alter phenytoin steady-state serum concentration or pharmacokinetics.

Neurology. 1988 Apr;38(4):639-42. doi: 10.1212/wnl.38.4.639.

The influence of diphenylhydantoin on primidone metabolism.

Arch Neurol. 1974 Mar;30(3):259-62. doi: 10.1001/archneur.1974.00490330067012.

[Phenobarbital intoxication in a patient with primidone and diphenylhydantoin (author's transl)].

Rev Med Chil. 1980 Aug;108(8):716-20.

Effects of phenobarbital or SKF 525A pretreatment on diphenylhydantoin disposition in pregnant mice.

Toxicol Appl Pharmacol. 1971 Dec;20(4):573-81. doi: 10.1016/0041-008x(71)90262-6.

[Serum beta-glucuronidase activity in patients treated with phenobarbital and diphenylhydantoin].

Arch Farmacol Toxicol. 1982 Apr;8(1):37-44.

The metabolism of 5,5-diphenylhydantoin (DPH) in nonpregnant and pregnant Rhesus monkeys.

Arch Int Pharmacodyn Ther. 1973 May;203(1):72-91.

引用本文的文献

Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.

Eur J Drug Metab Pharmacokinet. 1981;6(2):99-108. doi: 10.1007/BF03189475.

Anticonvulsant drugs. An update.

Drugs. 1984 Apr;27(4):328-63. doi: 10.2165/00003495-198427040-00003.

Drug metabolism and interaction with particular reference to the liver.

Drugs. 1971;2(3):177-89. doi: 10.2165/00003495-197102030-00001.

Effect of diphenylhydantoin on hepatic drug hydroxylation.

Eur J Clin Pharmacol. 1974 Jul 26;7(4):281-5. doi: 10.1007/BF00560345.

Anticonvulsant drugs. II. Clinical pharmacological and therapeutic aspects.

Drugs. 1972;4(3):256-82. doi: 10.2165/00003495-197204030-00004.

Drug eruptions.

Calif Med. 1970 Jul;113(1):23-31.

Pharmacokinetic drug interactions with phenytoin (Part II).

Clin Pharmacokinet. 1990 Feb;18(2):131-50. doi: 10.2165/00003088-199018020-00004.

Renal function and the rate of disappearance of methotrexate from serum.

Eur J Clin Pharmacol. 1975 Aug 14;8(6):439-44. doi: 10.1007/BF00562319.

Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.

Clin Pharmacokinet. 1976 Nov-Dec;1(6):444-52. doi: 10.2165/00003088-197601060-00004.

Drug interactions and clinical pharmacokinetics.

Clin Pharmacokinet. 1976;1(5):351-72. doi: 10.2165/00003088-197601050-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验